Why Ardelyx Stock Is Getting Crushed Today
The FDA doesn’t appear to be impressed by the biotech’s experimental kidney disease drug.
The FDA doesn’t appear to be impressed by the biotech’s experimental kidney disease drug.
Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences,…
ARW is an undervalued technology stock, with potential to grow sustainably with the sector as a whole due to its wide coverage…
Nasdaq Inc (NDAQ.O) said on Tuesday it had partnered with major U.S. banks, including Goldman Sachs Group Inc (GS.N), C…
SAN DIEGO, July 20, 2021 (GLOBE NEWSWIRE) — The Shareholders Foundation, Inc. announces that a lawsuit is pending for certain…
Dow futures bounced Tuesday, one day after the 30-stock average had its worst session in eight months.
Slumping Stocks Might Derail Busiest-Ever Summer for IPO Market BloombergQuint
Welcome to Money Diaries where we are tackling the ever-present taboo that is money. We’re asking real people how they spend…
Suzano benefits structurally from COVID-19 habit changes in its end markets. Check why SUZ stock is a great commodity long that…
NEW YORK, July 20, 2021 /PRNewswire/ — Starboard Value LP (together with its affiliates, “Starboard” or “we”), one of the largest…